

Type II pneumocytes are most affectedresulting
in decreased surfactant production
Fig 6Dcan lead
to reduced surfactant production
a reduction in pulmonary blood flowcan cause
a decrease in surfactant production
This condition ... genetic conditionscause
reduced surfactant production
to type 2 pneumocytesresulting
in decreased surfactant production
Decreased inflation of the alveolialso leads
to decreased surfactant production
on the other hand type II pneumocyte abnormalitieslead
to reduced surfactant production
although a normal number of AECII existmay contribute
to decreased surfactant production
prematurity or other conditions such as maternal diabetes(passive) caused by
Decreased surfactant production
alveolar collapse and hyaline membrane formationcauses
alveolar collapse and hyaline membrane formation
in persistently increased end - inspiratory Paw valuesresulted
in persistently increased end - inspiratory Paw values
to reduced lung compliance and impaired replacement of damaged AECIleads
to reduced lung compliance and impaired replacement of damaged AECI
to an alveolar stability and microatelectasisleading
to an alveolar stability and microatelectasis
in bruising , swelling , and redness in that area on CT scanresulting
in bruising , swelling , and redness in that area on CT scan
to atelectasisleads
to atelectasis
lungs to become stiffcauses
lungs to become stiff
from a compensatory secretion of insulin by the fetusresulting
from a compensatory secretion of insulin by the fetus
to respiratory distressleading
to respiratory distress